eGFR values and mean eGFR change after the use of dulaglutide.

eGFR values and mean eGFR change after the use of dulaglutide.

<p>(A, B) The use of dulaglutide was associated with a significantly less decline of eGFR (paired t-test, P = 0.003). (C, D) The reduced decline in eGFR was more clearly observed in patients with moderate-to-severe CKD.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Sungmin Kim (628527) (author)
مؤلفون آخرون:	Jung Nam An (9301900) (author), Young Rim Song (13242926) (author), Sung Gyun Kim (11758004) (author), Hyung Seok Lee (13242929) (author), AJin Cho (4524091) (author), Jwa-Kyung Kim (756295) (author)
منشور في:	2022
الموضوعات:	Medicine Genetics Molecular Biology Marine Biology Cancer Science Policy Infectious Diseases Virology two tertiary hospitals good therapeutic option body mass index 3 ), 31 type 2 diabetes least 3 months chronic kidney disease 5 ), 46 subgroup analysis showed severe ckd treated 4 ), respectively 8 ± 6 5 ± 5 1 ± 3 8 ± 4 renal protective effect mean hba1c level mean egfr change 0 ± 8 xlink "> dulaglutide 2 </ sup xlink "> 4 ), ± 1 – 2 renal function mean egfr mean decrease kidney outcomes ckd 2 6 kg 16 months – 0 weekly dulaglutide similar across reduced decline per year median duration lowering efficacy january 2017 improved cardiovascular december 2020 ckd stage ckd ). >- test 003 ). 0 %,
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!